Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1997 Oct;105(10):1060–1067. doi: 10.1289/ehp.971051060

Inorganic arsenic: a need and an opportunity to improve risk assessment.

W R Chappell 1, B D Beck 1, K G Brown 1, R Chaney 1, R Cothern 1, C R Cothern 1, K J Irgolic 1, D W North 1, I Thornton 1, T A Tsongas 1
PMCID: PMC1470381  PMID: 9349827

Abstract

This paper presents views on the current status of (inorganic) arsenic risk assessment in the United States and recommends research needed to set standards for drinking water. The opinions are those of the Arsenic Task Force of the Society for Environmental Geochemistry and Health, which has met periodically since 1991 to study issues related to arsenic risk assessment and has held workshops and international conferences on arsenic.The topic of this paper is made timely by current scientific interest in exposure to and adverse health effects of arsenic in the United States and passage of the Safe Drinking Water Act Amendment of 1996, which has provisions for a research program on arsenic and a schedule mandating the EPA to revise the maximum contaminant level of arsenic in drinking water by the year 2001. Our central premise and recommendations are straightforward: the risk of adverse health effects associated with arsenic in drinking water is unknown for low arsenic concentrations found in the United States, such as at the current interim maximum contaminant level of 50 microg/l and below. Arsenic-related research should be directed at answering that question. New epidemiological studies are needed to provide data for reliable dose-response assessments of arsenic and for skin cancer, bladder cancer, or other endpoints to be used by the EPA for regulation. Further toxicological research, along with the observational data from epidemiology, is needed to determine if the dose-response relationship at low levels is more consistent with the current assumption of low-dose linearity or the existence of a practical threshold. Other recommendations include adding foodborne arsenic to the calculation of total arsenic intake, calculation of total arsenic intake, and encouraging cooperative research within the United States and between the United States and affected countries.

Full text

PDF
1060

Images in this article

1060p1060-a
on p.1060
1061Figure 1.
on p.1061

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bates M. N., Smith A. H., Hopenhayn-Rich C. Arsenic ingestion and internal cancers: a review. Am J Epidemiol. 1992 Mar 1;135(5):462–476. doi: 10.1093/oxfordjournals.aje.a116313. [DOI] [PubMed] [Google Scholar]
  2. Brown K. G., Boyle K. E., Chen C. W., Gibb H. J. A dose-response analysis of skin cancer from inorganic arsenic in drinking water. Risk Anal. 1989 Dec;9(4):519–528. doi: 10.1111/j.1539-6924.1989.tb01263.x. [DOI] [PubMed] [Google Scholar]
  3. Brown K. G., Chen C. J. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan. Risk Anal. 1995 Aug;15(4):475–484. doi: 10.1111/j.1539-6924.1995.tb00340.x. [DOI] [PubMed] [Google Scholar]
  4. Brown K. G., Guo H. R., Kuo T. L., Greene H. L. Skin cancer and inorganic arsenic: uncertainty-status of risk. Risk Anal. 1997 Feb;17(1):37–42. doi: 10.1111/j.1539-6924.1997.tb00841.x. [DOI] [PubMed] [Google Scholar]
  5. Carlson-Lynch H., Beck B. D., Boardman P. D. Arsenic risk assessment. Environ Health Perspect. 1994 Apr;102(4):354–356. doi: 10.1289/ehp.94102354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cebrián M. E., Albores A., Aguilar M., Blakely E. Chronic arsenic poisoning in the north of Mexico. Hum Toxicol. 1983 Jan;2(1):121–133. doi: 10.1177/096032718300200110. [DOI] [PubMed] [Google Scholar]
  7. Chen C. J., Chen C. W., Wu M. M., Kuo T. L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992 Nov;66(5):888–892. doi: 10.1038/bjc.1992.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen C. J., Chuang Y. C., Lin T. M., Wu H. Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985 Nov;45(11 Pt 2):5895–5899. [PubMed] [Google Scholar]
  9. Chen C. J., Chuang Y. C., You S. L., Lin T. M., Wu H. Y. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer. 1986 Mar;53(3):399–405. doi: 10.1038/bjc.1986.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen C. J., Wu M. M., Lee S. S., Wang J. D., Cheng S. H., Wu H. Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 1988 Sep-Oct;8(5):452–460. doi: 10.1161/01.atv.8.5.452. [DOI] [PubMed] [Google Scholar]
  11. Del Razo L. M., García-Vargas G. G., Vargas H., Albores A., Gonsebatt M. E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrián M. E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol. 1997;71(4):211–217. doi: 10.1007/s002040050378. [DOI] [PubMed] [Google Scholar]
  12. Foy H. M., Tarmapai S., Eamchan P., Metdilogkul O. Chronic arsenic poisoning from well water in a mining area in Thailand. Asia Pac J Public Health. 1992;6(3):150–152. doi: 10.1177/101053959200600306. [DOI] [PubMed] [Google Scholar]
  13. Hopenhayn-Rich C., Biggs M. L., Fuchs A., Bergoglio R., Tello E. E., Nicolli H., Smith A. H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology. 1996 Mar;7(2):117–124. doi: 10.1097/00001648-199603000-00003. [DOI] [PubMed] [Google Scholar]
  14. Hopenhayn-Rich C., Biggs M. L., Smith A. H., Kalman D. A., Moore L. E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect. 1996 Jun;104(6):620–628. doi: 10.1289/ehp.96104620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hopenhayn-Rich C., Smith A. H., Goeden H. M. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res. 1993 Feb;60(2):161–177. doi: 10.1006/enrs.1993.1024. [DOI] [PubMed] [Google Scholar]
  16. Hsueh Y. M., Cheng G. S., Wu M. M., Yu H. S., Kuo T. L., Chen C. J. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver disease and malnutritional status. Br J Cancer. 1995 Jan;71(1):109–114. doi: 10.1038/bjc.1995.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mushak P., Crocetti A. F. Risk and revisionism in arsenic cancer risk assessment. Environ Health Perspect. 1995 Jul-Aug;103(7-8):684–689. doi: 10.1289/ehp.95103684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Rudel R., Slayton T. M., Beck B. D. Implications of arsenic genotoxicity for dose response of carcinogenic effects. Regul Toxicol Pharmacol. 1996 Apr;23(2):87–105. doi: 10.1006/rtph.1996.0031. [DOI] [PubMed] [Google Scholar]
  21. Slayton T. M., Beck B. D., Reynolds K. A., Chapnick S. D., Valberg P. A., Yost L. J., Schoof R. A., Gauthier T. D., Jones L. Issues in arsenic cancer risk assessment. Environ Health Perspect. 1996 Oct;104(10):1012–1018. doi: 10.1289/ehp.104-1469498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Smith A. H., Biggs M. L., Hopenhayn-Rich C., Kalman D. Arsenic risk assessment. Environ Health Perspect. 1995 Jan;103(1):13–17. doi: 10.1289/ehp.9510313b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Smith A. H., Hopenhayn-Rich C., Bates M. N., Goeden H. M., Hertz-Picciotto I., Duggan H. M., Wood R., Kosnett M. J., Smith M. T. Cancer risks from arsenic in drinking water. Environ Health Perspect. 1992 Jul;97:259–267. doi: 10.1289/ehp.9297259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Tseng W. P., Chu H. M., How S. W., Fong J. M., Lin C. S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 1968 Mar;40(3):453–463. [PubMed] [Google Scholar]
  25. Tseng W. P. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect. 1977 Aug;19:109–119. doi: 10.1289/ehp.7719109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vahter M., Marafante E. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett. 1987 Jun;37(1):41–46. doi: 10.1016/0378-4274(87)90165-2. [DOI] [PubMed] [Google Scholar]
  27. Warner M. L., Moore L. E., Smith M. T., Kalman D. A., Fanning E., Smith A. H. Increased micronuclei in exfoliated bladder cells of individuals who chronically ingest arsenic-contaminated water in Nevada. Cancer Epidemiol Biomarkers Prev. 1994 Oct-Nov;3(7):583–590. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES